All subjects
Technology & Suppliers

Synthetic Genomics changes corporate name to Viridos

Synthetic Genomics changes corporate name to Viridos
Synthetic Genomics Inc. begins operating under its new corporate name, Viridos, Inc. (photo courtesy Synthetic Genomics).

In the United States (US), Synthetic Genomics, Inc., a privately held biotechnology company, has announced that it will begin operating under its new corporate name, Viridos, Inc., effective September 27, 2021.

An error occurred

You are logged in as subsbriber at Bioenergy International, but something is wrong.

On your profile you can see what subscriptions you have access to and more information.

Is some of the information wrong – please contact our customer service.

Please reload the page

We could not ascertain if you are logged in or not. Please reload this page.
Bioenergy International premium

Do you want to read the whole article?

Only logged in payed subscribers can read all contents on bioenergyinternational.com
As an subscriber you get:
  • Six editions per year
  • Full access to all digital content
  • The E-magazine Bioenergy international
  • And more ...

The name change from Synthetic Genomics to Viridos is part of the company’s broader effort to deploy its cutting-edge genomic expertise and algal engineering platforms that create transformative solutions to climate change.

The name Viridos, drawn from the Latin word “viridis”, translating to green and fresh, represents our company’s mission to design revolutionary technologies, products, and systems that enable businesses and governments to implement sustainable solutions needed to mitigate climate change. It is my hope that our new name, Viridos, not only signals our best-in-class algal biotechnology but also becomes a byword for a new bioeconomy of solutions that enable the world to decarbonize and build more sustainable systems, said Dr Oliver Fetzer, CEO at Viridos.

Founded in 2005 by leading figures in synthetic biology, including J Craig Venter and Hamilton Smith, Synthetic Genomics/Viridos quickly established itself as a powerhouse for innovative research, transplanting the first genome, synthesizing the first bacterial genome, and creating the first synthetic cell.

In addition to its work in sustainable algal biofuel, Viridos is deploying its expertise in algal genomics, photosynthesis, and advanced agronomics to decarbonize other industries that need to operate more sustainably.

Viridos’ algal biofuel research is part of a 12-year partnership with ExxonMobil to bring advanced biofuels to the transportation market.

Our work with Viridos has helped advance the science of algae as a next-generation biofuel and a lower-emission alternative for heavy transportation. ExxonMobil is committed to researching, developing, and deploying lower-carbon energy technologies that help society achieve its net zero ambitions, said Dr Vijay Swarup, VP for Research and Development at ExxonMobil Research and Engineering Company.

Most read on Bioenergy International

Get the latest news about Bioenergy

Subscribe for free to our newsletter
Sending request
I accept that Bioenergy International stores and handles my information.
Read more about our integritypolicy here